Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They are trying very very hard. Hold and don't let them get their hands on your shares
I think the perceptive Board members will have been aware of his/her motives since mid-June when he/she first visited this MB
Just for clarity, Lykiri's post suggested £150K for 1st year and then £25K for each dose in subsequent years. Still well within NICE QALY (IMHO)
do you know how much stock the buyer acquired to help this on its way BSB?
It was Cognate that supported the clinical trial. I cannot imagine why one would thank CRL as they had nothing to do with the manufacturing/trial
Advent seems to have a knack of recruiting exceptional talent
I do tend to agree. The focus has to be entirely on getting DCVax-L approved in at least one jurisdiction and giving AF any publicity risks diluting the good story. The lawyers can go after him once this is achieved. Anything else at this moment in time is a distraction.
This is the first time I have seen AF in person and was a bit taken aback. I nearly gave him 5 bucks for a hot meal
The man is spineless. He reports totally false information and seems to totally unaccountable for his actions. Shame on the SEC for not investigating his actions
insert-text-here
Quite a few stories like this hitting the UK press
...if not a touch desperate
....and after that from rats to humans
A mistake to underestimate her IMO
Have been following your huge number of posts over the past several weeks. I think I finally get it, you don't rate the management.
Would be interested to see if there is any traction for NWBO over there already. Would love to see those of the cabal toasted
just a point of accuracy, she is Dr Coussens not Cousins
I too have written to the Editor saying very similar things.
This is spiteful and totally uncalled for. Mods should remove this post
This is a travesty.
Data clearly shows a highly significant improvement in overall survival for both ndGBM and (more amazingly) rGBM.
This was clearly a coordinated attack on the company by the cabal with it's poisonous mouthpiece doing the dirty work.
Real life: Patients suffer and die needlessly whilst this treatment is not approved. Public losing savings unnecessarily
I would mention conscience, morals and ethics but clearly those behind this attack clearly have none of these. Shameful.
There is no doubt in my mind that this will be approved and will replace SOC.
Hold on tight to your shares.
agree, utter madness
Great explanation
TY Magrit. interesting names in attendance
would somebody be able to post an updated list of attendees at the NYAS meeting please?
early morning bear raid?
anyone selling is bonkers
you nailed it again Soj
Brilliant summary, should be stickied
Low volume again reflects a quiet MB today. When do we move passed the elusive 1$? MMs at play
This is not true. I was co-author on a paper in one of the high impact factor medical journals that did exactly that
I liked One Day in the Life of Ivan Denisovich - great book
Jim, there is an enormous wealth of information from posters here who are forensic when conducting their due diligence. Then there are posters that just spout garbage with no facts. Most of us know the difference. They appear on Yahoo also, which is very telling.
I managed to get through Tolstoy’s War and Peace. God, it was dull and boring. Then I read Sir Ps posts……
I have worked in the field of cancer research for more than 2 decades. I have co-authored papers that were published in NEJM (x2), Lancet (x3), Cell and several other high impact factor journal. One of our papers was published online in Lancet within 5 weeks of submission. Two took just under a year as we
had to perform additional experiments to clarify the concerns raised by reviewers.
Most of the manuscript submissions have taken between 2-6 months to be published.
There can be a wide variety of reasons for a lengthy period between submission and publication. Most journals will get an initial response out to the authors within 4-6 weeks.
However, this can lead to 1) outright rejection - the manuscript has to be rewritten/reformatted for submission to another journal; 2) major amendments suggested before acceptance - this can range from the need for a reworking of any statistical analysis, additional experiments needed, justification for statements in the discussion, and this can taken many months; and 3) minor modifications required before the peer reviewers and the editor can accept.
Utter nonsense
It is always beneficial and of interest to hear from all sides of the NWBO iHub spectrum. However, just decided to hit the ignore button for only the third time. Oh! nearly forgot......eye roll
It is so clear from the huge response to the untimely passing of Gary's sister, how high a regard everyone has for him and his always polite, always considered contribution to the MB.
My sincere condolences Gary, very sad news.